Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype - PubMed (original) (raw)

. 1997 Nov;151(5):1215-24.

Affiliations

Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype

N Ortéga et al. Am J Pathol. 1997 Nov.

Abstract

The hypothesis that tumor growth is angiogenesis dependent has been documented by a considerable body of direct and indirect experimental data. A prerequisite for the development of novel anti-angiogenic agents is the design of drugs that would be active only on those endothelial cells with an angiogenic phenotype. We took advantage of the anti-idiotypic strategy to obtain circulating agonists specific for the vascular endothelial growth factor receptor KDR/flk-1 (J-IgG). They induced in the absence of VEGF cell proliferation in vitro and angiogenesis in the corneal pocket assay either through local or systemic delivery. Intraperitoneal injections of J-IgG in nude mice grafted with a prostatic adenocarcinoma led to tumor enlargement associated with an increase in both tumor vascularization and proliferation. In contrast KDR/flk-1 overstimulation had no detectable effect on normal tissues. These data underline that KDR/flk-1 is a functional marker of the angiogenic phenotype of endothelial cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1995 Jul 6;376(6535):62-6 - PubMed
    1. Am J Pathol. 1995 May;146(5):1029-39 - PubMed
    1. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6374-8 - PubMed
    1. J Cell Physiol. 1995 Aug;164(2):385-94 - PubMed
    1. Nat Med. 1995 Jan;1(1):27-31 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources